Clinical trial
Repetitive Transcranial Magnetic Stimulation (rTMS) as an Early Intervention in Major Depression (MD) Compared to Antidepressant Selective Serotonin Reuptake Inhibitor (SSRI) Medication (Early-TMS)
NCT06545474 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Repetitive Transcranial Magnetic Stimulation (rTMS) as an Early Intervention in Major Depression (MD) Compared to Antidepressant Selective Serotonin Reuptake Inhibitor (SSRI) Medication (Early-TMS)
- Lead sponsor
- University Hospital Tuebingen
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 15, 2024
- Completion date
- December 31, 2026
- Enrollment
- 106 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.